Paper Details

  1. Home
  2. Paper Details

[The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].

Author: ChenJiang-ting, GongXue-jie, HanLian-jun, KangWen-xue, LiSheng-ping, LiuChong-bai, RenYi-feng, RenYin-hai, WuWen-ting, XueWei-hua, ZhangYu-cheng

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Healive inactivated hepatitis A vaccine is safe and highly immunogenic in children. A dose of 250 U is considered appropriate for children, and the vaccine can be used for emergency vaccination.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate the safety, immunogenicity and fit dosage of Healive inactivated hepatitis A vaccine (HAV) in children. METHODS: A total of 85 susceptible aged 4 - 10 years with HAV seronegative children, had been enrolled from two adjacent villages in a county. The volunteers were randomize...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/14687502

データ提供：米国国立医学図書館（NLM）

Protecting Children from Hepatitis A: A Camel's Journey to Immunity

The world of [vaccines] is a vast desert, where protecting children from infectious diseases is a top priority. This study, like a camel seeking a safe haven, investigates the safety and efficacy of [Healive inactivated hepatitis A vaccine] in children. The researchers found that the vaccine was [well-tolerated] and highly [immunogenic] in children aged 4 to 10 years. This discovery is like finding a refreshing oasis in the desert of [vaccine development], offering a safe and effective way to protect children from this potentially serious infection.

A Safe Haven: A Camel's Oasis of Protection

The study provides reassuring evidence for the safety and efficacy of [Healive inactivated hepatitis A vaccine] in children. The researchers found that the vaccine was [well-tolerated] and highly [immunogenic], offering a valuable tool for protecting children from [hepatitis A]. This discovery is like finding a safe oasis in the vast desert of potential threats, offering a sense of security and peace of mind for parents.

Protecting Our Young: A Camel's Wisdom

This study highlights the importance of [vaccination] in protecting children from infectious diseases. It’s a reminder that even in the vast and sometimes unpredictable desert of health threats, there are effective tools that can help us safeguard the well-being of our children. By embracing [vaccination], we can create a safer and healthier future for generations to come.

Dr. Camel's Conclusion

This study demonstrates the safety and effectiveness of Healive inactivated hepatitis A vaccine in children. It's a reminder that vaccination is a valuable tool for protecting our children from infectious diseases, providing a safe haven in the vast desert of potential health threats.

Date :
  1. Date Completed 2004-05-20
  2. Date Revised 2006-11-15
Further Info :

Pubmed ID

14687502

DOI: Digital Object Identifier

14687502

Related Literature

Article Analysis
・Side Effects of hepatitis a vaccine
SNS
PICO Info
in preparation
Languages

Chinese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.